Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Lancet. 2021 Feb 18;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Online ahead of print.
No abstract available

Publication types

  • Letter